CAR T-cell therapy drives long-term remission in 8 SLE patients
A CAR T-cell therapy cleared disease-causing autoantibodies from the bloodstream of eight SLE patients without compromising vaccine response.| Lupus News Today
A CAR T-cell therapy cleared disease-causing autoantibodies from the bloodstream of eight SLE patients without compromising vaccine response.| Lupus News Today
The Lupus Landmark Study is a key part of Lupus Nexus, a first-of-its-kind lupus registry and collaborative research resource.| Lupus News Today
Mary M. Chapman began her professional career at United Press International, running both print and broadcast desks. She then became a Michigan correspondent for what is now Bloomberg BNA, where she mainly covered the automotive industry plus legal, tax and regulatory issues. A member of the...| Lupus News Today
Most patients with systemic lupus erythematosus (SLE) experience joint pain, typically in the hands, wrists, and knees, a study found.| Lupus News Today
Lupus Therapeutics is teaming up with Artiva Biotherapeutics on a Phase 1 trial of AlloNK, a natural killer cell therapy for lupus nephritis.| Lupus News Today
The LRA will give up to $600,000 to each of its seven Lupus Mechanisms and Targets Award recipients to develop better treatments for lupus.| Lupus News Today
